Marten Ferno
Medicon Village
Lund, M 22381, Sweden
Lund, M 22381, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 141 publications
Breast cancer hormone receptor levels and benefit from adjuvant tamoxifen in a randomized trial with long-term follow-up.
Journal: Acta oncologica (Stockholm, Sweden)
Published: April 05, 2024
Hormone receptor mRNA and protein levels as predictors of premenopausal tamoxifen benefit.
Journal: Acta oncologica (Stockholm, Sweden)
Published: September 28, 2023
Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer: data from the randomized SBII:2 trial.
Journal: Breast cancer research : BCR
Published: June 28, 2023
Reply to V. Nardone et al.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 06, 2023
Development and Validation of a Genomic Profile for the Omission of Local Adjuvant Radiation in Breast Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 04, 2023
Proteogenomics decodes the evolution of human ipsilateral breast cancer.
Journal: Communications biology
Published: August 06, 2022
The Prognostic Role of Intratumoral Stromal Content in Lobular Breast Cancer.
Journal: Cancers
Published: December 13, 2021
Breast cancer hypoxia in relation to prognosis and benefit from radiotherapy after breast-conserving surgery in a large, randomised trial with long-term follow-up.
Journal: British journal of cancer
Published: July 04, 2021
Disseminated tumour cells from the bone marrow of early breast cancer patients: Results from an international pooled analysis.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 16, 2021
St Gallen 2019 guidelines understage the axilla in lobular breast cancer: a population-based study.
Journal: The British journal of surgery
Published: February 16, 2021
High CYP27A1 expression is a biomarker of favorable prognosis in premenopausal patients with estrogen receptor positive primary breast cancer.
Journal: NPJ breast cancer
Published: January 23, 2021
Last Updated: 09/26/2026